Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Investigation of the relationship between the material properties of insoluble, protein aggregates known as amyloids and common forms of age-related dementia such as Alzheimer’s and Parkinson’s

NANOMECHAMYLOID

The conversion of normally soluble and functional proteins into insoluble protein aggregates known as amyloids are linked to more than 50 human disorders, including several common forms of age-related dementia such as Alzheimer’s and Parkinson’s diseases. Amyloids exist as long, rope-like structures known as fibrils which can self-associate into...

Funding Programme
Start Date
End Date
Total Funding
€ 282 561
European Countries Involved

Label Free Nanoscopy Using Infra Red

LANIR

Every year, Alzheimer's disease (AD) affects about 800,000 new patients in Europe and directly causes 50% of dependency of aged persons. Currently there is no test to diagnose this disease. There is a great need to improve outcomes for patients with lung cancer which causes between 15-28% of all cancer deaths in Europe. Chemical and structural...

Funding Programme
Start Date
End Date
Total Funding
€ 5 456 348
European Countries Involved

Large scale interactions in brain networks and their breakdown in brain diseases

BRAINSYNC

The long-term goal of this project is to understand how neuronal assemblies exchange information (functional or neuronal communication), and how variability in neuronal communication explains variability in behavioural performance, both in the intact and injured brain. Communication involves temporal interactions between neuronal assemblies either...

Funding Programme
Start Date
End Date
Total Funding
€ 3 933 811
European Countries Involved

Luminescent polymers for in vivo imaging of amyloid signatures

LUPAS

In this project we seek to develop new smart imaging molecular tools for combating neurodegenerative diseases such as Alzheimer’s disease and prion diseases. Emphasis is put on translational applied research for the development and validation of novel properly functionalized luminescent conjugated polymers (LCP) that via modern imaging technology...

Funding Programme
Start Date
End Date
Total Funding
€ 6 475 643
European Countries Involved

Magnetic Resonance Methods Development and Applications for Life Sciences

EUROCANMRI

This application is to enable mutual transfer of knowledge and experience by enhancing mutual scientific interest, augmenting research projects and exchanging new ideas. We envision that the collaboration will bring joint publications and new discoveries in the area of Magnetic Resonance (MR). The project aims at the improvement of current...

Funding Programme
Start Date
End Date
Total Funding
€ 91 800
European Countries Involved

Mechanobiology of Aplysia neurons

MAPNE

Memory loss is a central symptom in different diseases such as Alzheimer’s disease, and represents a significant social and economic burden for a large percentage of European citizens. Neuronal cell adhesion molecules belonging to the immunoglobulin superfamily (IgCAMs) are known to be involved in brain development processes, and also contribute to...

Funding Programme
Start Date
End Date
Total Funding
€ 178 374
European Countries Involved

Membrane-active peptides across disciplines and continents: An integrated approach to find new strategies to fight bacteria, dengue virus and neurodegeneration

MEMPEPACROSS

Peptide-lipid interactions are critical in several biomedical matters that seem uncorrelated at a first glance. MEMPEPACROSS deals with some of these: 1) Lipid membrane-interactions are the key for the understanding of dengue virus assembly and can constitute a target for its inhibition. Viral hemorrhagic fever caused by dengue virus is a serious...

Funding Programme
Start Date
End Date
Total Funding
€ 181 800
European Countries Involved

Memory loss in Alzheimer disease: underlying mechanisms and therapeutic targets

MEMOSAD

MEMOSAD aims at defining the molecular mechanisms of Abeta- and Tau-induced synaptotoxicity and at developing disease-modifying therapeutics for the prevention of memory loss in Alzheimer disease (AD). Insoluble aggregates of the two proteins provide the pathological hallmarks of this incurable brain disorder. Early stage AD is characterized by a...

Funding Programme
Start Date
End Date
Total Funding
€ 4 023 080
European Countries Involved

METABOLIC BASIS OF NEURODEGENERATIVE DISEASE

BEYOND

Alzheimer disease (AD) is the most common form of age-related dementia affecting millions of patients worldwide. Disturbingly, disorders of lipid and glucose metabolism emerge as major risk factors for onset and progression of neurodegeneration in the human population. Thus, an increasing life expectance combined with an observable rise in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 415 229
European Countries Involved

Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics

MITOTARGET

Mitochondrial dysfunction is a major hallmark of various neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s diseases or Amyotrophic Lateral Sclerosis (ALS). However linking mitochondrial dysfunction to the pathogenesis of some of these diseases still needs to be elucidated. Furthermore, in pathologies where...

Funding Programme
Start Date
End Date
Total Funding
€ 10 332 038
European Countries Involved

Modelling and Inference on brain Networks for Diagnosis

MIND

Graphs are used in modern neuroscience to represent structural and functional connectivity of the brain acquired using magnetic resonance imaging. A number of pathologies affect these networks: their study holds vast promise for understanding and diagnosing brain diseases. But brain connectivity data is not trivial to process, and the predominant...

Funding Programme
Start Date
End Date
Total Funding
€ 275 363
European Countries Involved

Molecular mechanism of amyloid β aggregation

MAMBA

Generation of toxic oligomers during aggregation of amyloid beta peptide (Abeta42) into amyloid fibrils is a central event in Alzheimer disease. Understanding the aggregation process is therefore one important step towards therapy and diagnosis of the disease. We propose a physical chemistry approach with the goal of finding the molecular...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 920
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).